Urethral Dilator Market Size to grow by USD 98.45 million between 2023-2027
According to a research report “ Urethral Dilator Market” by Product (Hydraulic urethral dilators, Others) End-user (Hospitals, ASCs, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2027 published by Technavio, the market size is estimated to grow by USD 98.45 million, at a CAGR of 5.98% during the forecast period. The global urethral dilator market is experiencing significant growth due to the increasing trend towards minimally invasive urological procedures. Healthcare professionals and patients are increasingly opting for these less invasive methods to treat conditions affecting the bladder, prostate, and kidney. Minimally invasive techniques, such as urethral dilatation, offer several advantages over traditional methods like urethroplasty and blind dilation, including reduced risk and faster recovery times. As a result, the demand for urethral dilators is poised to increase substantially in the coming years, with urologists increasingly adopting these tools to provide effective and efficient patient care..
Browse market data tables, figures, and in-depth TOC on “Urethral Dilator Market” by Product (Hydraulic urethral dilators, Others) End-user (Hospitals, ASCs, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2027. Download Free Sample
By Product, the Hydraulic urethral dilators segment is projected to dominate the market size in 2024
In the medical field, hydraulic urethral dilators are a cost-effective solution for urethral dilation during stricture treatment and procedures. These dilators consist of a pressurizer and a dilating tube. Hydraulic urethral dilation is an efficient technique for preventing stricture recurrence post-optical internal urethrotomy (OIU), with only 8.7% of the 23 patients in a study displaying recurrence during the 5-17 month follow-up period. Hydraulic self-dilation, which involves intermittent compression of the urethra during urination, is a patient-administered procedure recommended for 3 to 6 months following direct visual internal urethrotomy (DVIU). This non-invasive method offers a viable alternative to surgical interventions.
By End-user, Hospitals segment is expected to hold the largest market size for the year 2024
In the realm of urological procedures, hospitals predominantly perform surgeries such as renal surgery, nephrectomy, urethral surgery, bladder surgery, and prostatic surgery. Post-surgery, a catheter is inserted to divert urine, allowing the urethra to heal. Despite the minimal risk of infection during the procedure, high-risk patients, including those with long-term catheters, bladder removal, extended hospital stays, and frequent hospitalizations, face a heightened risk of hospital-acquired infections. Notably, the Urology Care Foundation estimates that approximately 33 million people reside with overactive bladder, and up to 25% of men and women experience urinary incontinence in the United States.
North America is forecasted to hold the largest market size by region in 2024
In the North American market, the United States represents a significant revenue generator. Factors such as the rising prevalence of lifestyle diseases and chronic conditions, increasing demand for endoscopic procedures, a growing geriatric population, and the introduction of technologically advanced urethral dilators are driving market growth. Key players like BD and Cook, with their strong market presence, contribute substantially to the region's revenue. Vendors are strategically expanding their product offerings and restructuring their sales forces to boost market penetration in North America. Additionally, the region's aging population continues to expand, further fueling demand for urethral dilators.
The Urethral Dilator Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The Urethral Dilator Market is witnessing significant growth due to the increasing prevalence of medical conditions such as Benign Prostatic Hyperplasia (BPH) in the geriatric population, Urinary Incontinence (UI), and Urinary Tract Infections (UTIs) in hospitals like Mount Sinai. The market is also driven by the high patient volume due to elective surgeries for medical conditions like kidney stones, prostate cancer, and urethral strictures. The recurrence of these conditions and surgical-related infections are major factors fueling the demand for urethral dilators. Factors such as birth defects, trauma, inflammation, fibrosis, and chronic kidney diseases also contribute to the market growth. Healthcare companies are investing in research and development to produce advanced urethral dilators to address the unique needs of patients. However, lockdown restrictions and surgical cancellations due to the COVID-19 pandemic have impacted the market growth. The baby boomer population's increasing prevalence of urinary diseases, urinary stones, and chronic kidney diseases will continue to drive the market in the forecast period.
Market Research Overview
The Urethral Dilator Market encompasses a range of medical instruments used in home care, ambulatory surgical centers, hospitals, clinics, and outpatient settings for treating various urological disorders. These dilators are essential for procedures like kidney stone removal, meatal stenosis, and prostate gland examination. The market offers both reusable and disposable options, with a focus on user-friendly designs, uniformity in performance, and quality. Sterilization and convenience are crucial considerations in the urethral dilator market. With the rise of viruses and bacteria, there is a growing demand for disposable urethral dilators to prevent cross-contamination. However, reusable dilators, which require proper cleaning and sterilization, continue to be popular in healthcare institutions due to their cost-effectiveness. Patient comfort is a significant factor in the market, with less discomfort and quicker recovery times being key therapeutic outcomes. Customized dilators, smoother insertion mechanisms, ergonomic handles, and flexibility and comfort are essential features. New materials like silicone are being explored for their patient-centric approach and effectiveness in treating related disorders, such as hyperplasia, benign prostatic hyperplasia (BPH), urinary tract infections (UTIs), urinary stones, and chronic kidney diseases. Healthcare facilities are increasingly offering minimally invasive treatments, including MI techniques for accurate diagnosis and effective treatment of urological issues like kidney cancer, advanced bladder cancer, and urethral strictures. Public awareness campaigns, online resources, seminars, and workshops are essential for early intervention and reducing the stigma and fear associated with urological conditions. Reimbursements and ease of use are critical factors for healthcare companies in the urethral dilator market. The geriatric population, with its increased patient volume and urological issues, is a significant market driver. Lockdown restrictions have led to an increase in elective surgeries, further boosting demand. However, recurrence, surgical-related infections, birth defects, trauma, inflammation, fibrosis, and urinary complications are challenges that the market must address.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/